Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK joins Novartis flu ban; Crucell vaccine suspended too

This article was originally published in Scrip

Executive Summary

The UK's MHRA (Medicines and Healthcare products Regulatory Agency) has asked Novartis to recall two batches of its Agrippal seasonal influenza vaccine, following action begun in Italy earlier this month after Novartis reported quality defects with the vaccine. The various European national agencies that have asked for precautionary recalls of the vaccine have emphasized that there is no current indication of a safety issue with the vaccines.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts